Skip to main content
Premium Trial:

Request an Annual Quote

Syrrx Gets $2M ATP Grant

NEW YORK, May 3 (GenomeWeb News) - Syrrx announced today that it has received an Advanced Technology Program grant from the National Institute of Standards and Technology to develop nanoscale arrays for improving the crystallization of membrane proteins.

 

The grant is for $2 million over three years, according to the ATP website.

 

The technology that the San Diego-based company hopes to develop with the grant money involves using a regularly-repeating nanoscale pattern to induce crystallization. The company plans to conduct over 100,000 experiments and will subcontract Santa Clara, Calif.-based Parallel Synthesis Technologies to engineer the nanoscale surfaces.

 

The new technology could reduce drug development time and costs, according to Syrrx.

 

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.